Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Conference Correspondent
News, views, and coverage of important topics and discussions from oncology conferences and events.
[widgetkit id="1" name="CC Event Nav"]
ASCO 2020 Lung Cancer Highlights
Read More
Impact of Immune-Related Adverse Events on Checkpoint Inhibitor Consolidation Therapy in Stage III NSCLC
Read More
Characteristics of Patients Who Achieve Long-Term Response with PD-1 Blockade
Read More
Smoking Cessation and Lung Cancer: Recent Quitters Benefit Too
Read More
Weekly Epirubicin as Second-Line Therapy for Malignant Pleural Mesothelioma
Read More
Patterns of Acquired Resistance in Patients with NSCLC Who Receive PD-1 Inhibitors
Read More
ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC
Read More
Cediranib Combined with Olaparib Is Active in Patients with Platinum-Pretreated SCLC
Read More
Nationwide Genomic Screening Network Can Be Effective in Identifying Rare Targetable Genetic Alterations
Read More
Combination of Nivolumab, Ipilimumab, and Chemotherapy in Metastatic NSCLC
Read More
1
2
3
4
Page 1 of 25
Results 1 - 10 of 242